Licensing & Regulatory Boards
State and national agencies responsible for licensing, certifying, and regulating psychedelic therapy practitioners.
All Organisations
Colorado DORA Natural Medicine Program
Colorado Division of Professions and Occupations program overseeing facilitator licensing, renewals, complaints, and rule/policy resources for natural medicine services.
Colorado Department of Natural Medicine (DOR)
Colorado Department of Revenue division responsible for licensing and regulating natural medicine businesses, including healing centers, cultivations, product manufacturers, and testing facilities.
Colorado Natural Medicine Advisory Board
Statutorily created Colorado advisory board providing implementation recommendations for natural medicine regulation, safety standards, licensing architecture, and program oversight priorities.
European Medicines Agency (EMA)
EU medicines regulator for scientific review and pharmacovigilance, including psychiatric products with psychedelic relevance.
Medicines and Healthcare products Regulatory Agency (MHRA)
UK medicines regulator overseeing trial authorizations, pharmacovigilance, and market-authorization pathways.
New Mexico Medical Psilocybin Advisory Board
State advisory board established under New Mexico medical psilocybin policy to guide program standards, implementation recommendations, and evidence-informed regulatory development.
Oregon Health Authority
Oregon state health authority administering Oregon Psilocybin Services licensing and implementation oversight.
Oregon Higher Education Coordinating Commission (HECC)
Oregon state education regulator that licenses private career schools and oversees approval pathways relevant to psilocybin facilitator training program operations in Oregon.
Oregon Psilocybin Advisory Board
State advisory board charged with issuing recommendations to Oregon Health Authority on psilocybin services implementation, professional standards, public health safeguards, and operational controls.
Swiss Federal Office of Public Health (FOPH)
Swiss federal authority issuing exceptional licences for otherwise prohibited narcotics, including controlled pathways relevant to psychedelic substances under medical/scientific exceptions.